Liver Health Supplements - Worldwide

Liver Health Supplements Market Definition

The liver health supplements market is growing at fastest rate as the unhealthy lifestyle choices are growing, including excessive alcohol consumption, poor diet, and busy lifestyle, the liver disorders are rising globally. As liver diseases and infection rise, consumers are turning to supplements to help in liver detoxification and overall health. The liver health supplements are dietary products developed to promote the proper functioning of liver. According to the World Health Organization (WHO), viral hepatitis causes 1.3 million fatalities annually, making it the second most common infectious cause of death worldwide. Increasing research and development activities for innovating and launch of the liver health supplements, which is estimated to drive the growth of the liver health supplements market in the future.

• In October, 2024, Central Marine Fisheries Research Institute, Research institute in Kerala, India, transferred technology to Emineotech Pt Ltd, which is currently being manufacturing it commercially under the name GreenRexTM. A special combination of all-natural bioactive compounds derived from particular seaweeds makes up the product. It is manufactured with environmentally friendly green technologies to enhance liver health. Grinson George, director of the CMFRI, stated that nutraceuticals of marine origin play a major role in healthcare sector, offering essential nutrients and potential disease fighting compounds to assist overall well-being.

While demand for liver health supplements continues to climb, stringent federal regulations around the production, competition from the alternative pharmaceutical drugs and spreading misinformation limit growth in the liver health supplements market. Liver detoxification products have gained attention, especially among customers interested in overall wellness. Liver health supplements usually play a significant role in detox regimens, offering an opportunity for manufacturers to market their products as part of a broader wellness concerns. In August 2024, ZBiotics, a San Francisco-based biopharmaceutical company that produces genetically modified probiotics, has raised US$12 million in a Series A fundraising round. The oversubscribed round was headed by Spring Tide Capital, with participation from Seaside Ventures, Goat Rodeo Capital, Seamless Capital, and Access Capital. The money will be used by ZBiotics to increase the number of retail locations it operates and to introduce more applications for its genetically modified probiotics.